Tag: CBAC

Compound may prevent risk of a form of arrhythmia from common medications (Links to an external site)

Jianmin Cui, KCNQ1

CBAC Jianmin Cui leads a multi-institutional team to make this discovery. Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome. While safe in their current dosages, some of these drugs may have a more therapeutic benefit at higher doses, but are limited by the risk of arrhythmia.

WashU-developed holograms help physicians during cardiac procedure (Links to an external site)

Jennifer Silva, Holographic Display

Holographic display improves physician accuracy when treating irregular heartbeat. CBAC members, Jennifer N. Avari Silva, MD, associate professor of pediatrics at the School of Medicine, and Jonathan Silva, associate professor of biomedical engineering in the McKelvey School of Engineering, co-led a team that tested a Microsoft HoloLens headset with custom software during cardiac ablation procedures on patients at St. Louis Children’s Hospital.

CBAC 10th Anniversary Symposium

CBAC Symposium, Cardiac Arrhythmias Symposium

On Friday, August 28th, the Cardiac Bioelectricity & Arrhythmia Center (CBAC) of Washington University held a one-day symposium celebrating its 10th anniversary. The symposium addressed basic research and clinical issues in the field of cardiac arrhythmias. Faculty included speakers from Washington University and guests from all around the world.